- 1988 Medical Degree
- 1991 Project Research performed abroad Italy. University of Umeå, Sweden
- 1993 Italian Ph.D. in Experimental Medicine, University of Perugia
- 1997 Specialisation in Clinical Pathology, Perugia University Medical School
- 2000-2006 Researcher,
- 2006-present. Associate Professor. University of Perugia.
- 2001-2006: Chair of Pharmacology, School of Motor and Sport Sciences, University of Perugia.
- 2006-present: Chair of Pharmacology, Medical School. University of Perugia.
- 2015-present: Coordinator of PhD School on "Pharmacological Biotecnology and Clinical Pharmacology”, University of Perugia
- Member of the "Italian Society of Pharmacology" (SIF)
- Member of the “European Academy of Sciences and Arts”
PUBLICATIONS AND METRICS
Publications in peer reviewed international journals: 91
Barbara is Professor at the University of Tasmania (UTAS), where she leads Aquatic Animal Health research group. Barbara has her PhD from Sydney University and has been working at UTAS since 1991. Her research interests focus on various aspects of fish health, such as fish parasitology, fish immunology and fish pathology. Barbara has published over 200 papers and supervised more than 30 PhD students. She has received awards for her research and supervision of PhD students.
Chair of Biochemistry at Trinity College Dublin & Academic Director of the Trinity Biomedical Sciences Institute. Awards include the Royal Irish Academy Medal for Biochemistry, The Irish Society for Immunology medal, the Royal Dublin Society/Irish Times Boyle medal for Scientific Excellence & the Science Foundation Ireland Researcher of the Year Award. Co-founder and director of Opsona Therapeutics. In 2008 he was appointed Chair of the Immunity & Infection panel of the European Research Council
Dr Masahiro Ono was originally trained as a dermatologist, and later specialised in molecular and systems immunology. He obtained his PhD in 2006 on autoimmunity and regulatory T cells, and thereafter, worked on the molecular mechanism of the transcription factor Foxp3, revealing the interaction of Foxp3 and the transcription factor Runx1 and their transcriptional mechanisms. In 2009, he obtained a Human Frontier Science Program Long-Term Fellowship, and joined University College London (UCL). Thus he extended his expertise to genomics and systems analysis, establishing a new multidimensional framework for visualising transcriptomic data and unravelling complex processes in T cell differentiation. In 2012, he was awarded a prestigious Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship, thereby established his lab in UCL. In 2015, he was appointed to a proleptic Senior Lecturer in the Department of Life Sciences, Imperial. He is conducting multidisciplinary projects on the transcriptional programme of T cell memory and immune regulation.
MD, Umuversity of Athens, Greece
PhD, Syracuse University, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy
Professor of Experimental Neuropathology at the Centre for Biological Sciences of the University of Southampton. Visiting Professor in the College of Medicine and Veterinary Medicine, University of Edinburgh. Fellow of the Academy of Medical Sciences. Chair of the Medical Research Council Neuroscience and Mental Health Board.
Associate Professor Molecular Cell and Developmental Biology. Presidential Young Investigator (1987).
Researcher at the Institute of Genetics and Biophysics of the National Research Council.
Carlo Pucillo is a Full Professor in Immunology at the School of Medicine of the University of Udine.
In his scientific career Prof. Carlo Pucillo has studied the "non canonical function" of MHC class II and the molecular mechanism that regulate the B cell activation and differentiation. From 2-1991 to 6-1994 Dr Pucillo has been Visiting Scientist at NCI in Bethesda, MD-USA.
He has acquired a considerable expertise in advanced molecular biology analysis as well as a good understanding of the immunobiology of the immune response, of the non canonical function of MHC class II molecules, in particular, as documented by his publications on this subjects.
He has also investigated the signal transduction pathways elicited by T-B cell interaction via CD40-CD154. CD40 is a B cell surface receptor that belongs to the pleiotropic tumor necrosis factor receptor (TNFR) superfamily. The interaction between CD40 and its ligand promotes proliferation, cytokine production, upregulation of various surface molecules involved in antigen presentation, germinal center and memory B cell formation antibody isotype switching and affinity maturation and the B cell life span.
Most recently, his interest is in the study of regulatory role of Mast Cells in the microenvironment and subsequently in the tissutal tolerance and adaptive immune response. This body of work may provide a conceptual framework to therapeutically manipulate these responses in the settings of autoimmune disease and cancer.
Prof. of Nephrology, Director of the Department of Immunology and Clinical Transplantation and Director of the Department of Medicine of the Ospedali Riuniti di Bergamo, Italy. Research Coordinator of the Negri Bergamo Laboratories of the Mario Negri Institute for Pharmacological Research. Recipient of ISN Jean Hamburger Award (2005), ASN John. P. Peters Award (2007), ISN AMGEN Award (2011). 2011 appointed as ISN President-elect (2013-2015)
Prof Thomas Ritter, leader of research programme, was recruited by the National University of Ireland, Galway as a lecturer in Gene Therapy and Regenerative Medicine and assumed his position in March 2005. Prof. Ritter has over 20 year experience in the field of gene therapy in organ transplantation. He obtained his Ph.D. degree in 1994 from the Max-Planck Research group of Immunology / Rheumatology at the University of Erlangen-Nuremberg, Germany where he worked on the molecular characterization of T cell receptors specific for human collagen type II. Having completed his Post-Doctoral Fellowship at Marseille, Center of Immunology in 1995, Prof. Ritter took up a faculty position at the prestigious Charité University Hospital in Berlin, Germany. He worked as a leader of the gene therapy programme in experimental transplantation in the Institute of Medical Immunology under the directorship of Prof. Dr. H.-D. Volk. His research focused on the development of efficient viral gene-transfer systems for application in transplantation medicine. Prof. Ritter was successful in obtaining funding from the German Research Foundation and the Ministry of Health and Research as well as from industry (Schering). Prof. Ritter completed his 'Habilitation' (postdoctoral lecture qualification) in Immunology in 2002 followed by a promotion to assistant professor in 2003.